Understanding and Diagnosing Allergic Disease in Twins

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01613885
First received: June 5, 2012
Last updated: July 8, 2014
Last verified: July 2014
  Purpose

The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.


Condition
Allergies

Study Type: Observational
Official Title: Understanding and Diagnosing Allergic Disease in Twins

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Comparing immune systems of food allergic twins [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Blood


Estimated Enrollment: 200
Study Start Date: August 2010
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Twins, ages 0 to 80 years, with or without allergy disease.

  Eligibility

Ages Eligible for Study:   up to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies. Women, minorities or children will not be excluded from this study.

Criteria

Inclusion Criteria:

  • Twin participants ages 0 to 80 years who are with or without allergy disease.

Exclusion Criteria:

  • Patients with special risks attendant to venipuncture will be excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01613885

Contacts
Contact: Kari A Nadeau, MD, PhD safar_scheduler@stanford.edu

Locations
United States, California
Stanford University School of Medicine Active, not recruiting
Stanford, California, United States, 94305
Stanford University Recruiting
Stanford, California, United States, 94305
Contact: Kari Nadeau, MD, PhD         
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Kari Nadeau, MD, PhD Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01613885     History of Changes
Other Study ID Numbers: SU-10042011-8546
Study First Received: June 5, 2012
Last Updated: July 8, 2014
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board

Additional relevant MeSH terms:
Diseases in Twins
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on September 16, 2014